Peptide FAQs

It depends on the specific peptide and how it’s supplied. Some are registered prescription medicines; many marketed online are unapproved and have no lawful supply pathway for human use.

For genuine prescription medicines, “no prescription required” is a red flag, not a convenience. Unapproved peptides sold this way sit outside the regulated system.

Only within the narrow conditions of the Personal Importation Scheme, which generally needs a valid prescription for prescription-type substances and excludes some goods entirely.

Yes, certain peptides, where clinically appropriate — sometimes via the SAS, Authorised Prescriber pathway or a compounding pharmacy. The peptide and the pathway both matter.

Safety depends on what the product is, where it came from, and whether anyone qualified is overseeing it. An approved, prescribed medicine is a very different risk to an unapproved online vial.

Unknown purity and concentration, possible contamination, no batch testing or recall mechanism, and no medical oversight. For many, long-term human safety data does not exist.

Many peptides are prohibited in sport under the World Anti-Doping Code, which is a separate framework from TGA regulation. Athletes should assume serious risk.

No — it is not ARTG-approved, and supply for human use generally is not lawful regardless of labelling.

Registered brand-name semaglutide is a lawful prescription medicine. Unapproved “compounded” or online versions are a different, riskier question.

It is unapproved, often counterfeit, and associated with side effects and changes to skin moles. Australian regulators have specifically warned against it.